Page 3 - World Use News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Discover the latest Internet statistics for 2023 in our comprehensive article, shedding light on the ever-evolving online landscape.

Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced the publication of findings from a retrospective, observational, single arm, European chart review study assessing the real-world use of extracorporeal photopheresis (ECP) and its impact on clinical outcomes in the modern era of heart transplantation.1 An online version of the data manuscript – the largest-known study of ECP in heart transplant patients – is currently published on the Journal of Hea

- Results from the largest European and first multicenter, retrospective, observational chart review study investigating the real-world use of ECP in heart transplant patients reinforce its

Expert perspectives on the real-world use of HER2-directed therapies in patients with HER2-amplified colorectal cancer.

- Plenary Scientific Session to highlight Incyte-discovered novel anti-mutant CALR-targeted monoclonal antibody INCA033989 - Data from three of the Company's LIMBER studies evaluating ruxolitinib